Replies to post #398 on Arrayit Corporation (ARYC)

[bart]

Fine by me. Nice buying opportunity.

Back to your last post JJ. Interesting to note that Agendia uses ArrayIt stuff. That's nice but something's wrong with that picture.

I'm sure ARYC recently came to the realization that it makes more corporate sense to partner with various agencies in developing and marketing tests than it does to just sell the equipment enabling others to do so.

At the moment we get indications that the company is working on tests for Parkinsons and H1N1. Prostate has also been rumored. So far, though, no indication as to whom they're partnering with in the other developments. H1N1 seems to be a bit of a non-issue these days but perhaps efforts are ongoing. The company talks about stepping up their information and marketing campaign in the coming year and I suspect we might see the partners identified in the short months ahead.

[JJBenzo]

I agree with Bart let them take it down there. Once the Settlement announcement from Jury award is announced this wont be anywhere near .80. All I can say is this good news if it does . that can only mean one thing. A financing is on its way and the funders want the price lower to get a better deal on discount to market. JMHO

Regardless of that, this will be positive news since they will be funded and take a half billion a year product to market which will be a fair trade for dilution. ALL bets are off When and if the Company gets the Total Jury award.

Link Here

Civil Action number 01-2226 between TeleChem International, Inc., Pediatrix Screening, Inc. and Pediatrix Screening LP went to jury trial in the United States District Court in the Western District of Pennsylvania in the summer of 2007. The jury awarded TeleChem $5 million in damages for Pediatrix's breach of contract, fraudulent misrepresentation, and punitive damages. The jury awarded Pediatrix $1,085,001 for TeleChem's breach of contract. Pediatrix appealed the jury's decision, and requested that the damages award to TeleChem be reduced. This appeal was denied. Pediatrix put $5 million in bond, and submitted an appeal to the Third Circuit Court of Appeals to request that the damages award to TeleChem be reduced. The parties await the Third Circuit Court's response.



Then they will be covering their short BIG TIME.